Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-04-26

FDA Approved: EZETIMIBE AND SIMVASTATIN — Original Application (Dr.Reddys Laboratories Inc)

View source ↗

Summary

FDA approved a new generic fixed-dose combination of ezetimibe and simvastatin from Dr. Reddy's Laboratories Inc under an Original Application.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EZETIMIBE AND SIMVASTATIN (ezetimibe and simvastatin)

Snippet

ORIG AP for EZETIMIBE AND SIMVASTATIN (EZETIMIBE AND SIMVASTATIN)